Announcements
OBI filed an Application of Phase II human clinical trial for Globo-H Antibody Drug Conjugate, OBI-999, to TFDA
1. Date of occurrence of the event: October 13, 2021 2. Company name: OBI Pharma Inc. 3. Relationship to the Company (please enter “head office” or “subsidiaries”): Head office 4. …
OBI Filed an Application of Investigational Device Exemption (IDE) for Phase II Cohort Expansion Human Clinical Trial for Globo H Antibody Drug Conjugate, OBI-999, to FDA
1.Date of occurrence of the event: September 29, 2021 2.Company name: OBI Pharma Inc. 3.Relationship to the Company (please enter “head office” or “subsidiaries”): Head office 4.Reciprocal shareholding ratios: Not …
Announcement on behalf of Amaran Biotechnology, Inc., a major subsidiary, that the Company’s Board of Directors resolved to revise the Regulations for Issuance and Subscription of 2020 Employee Stock Options
1.Date of the Board of Directors resolution: September 9, 2021 2.Issue period: Pursuant to Article 167-2 of the Company Act, issued at once or in tranches within 2 years from …
Announcement on behalf of Amaran Biotechnology, Inc., a major subsidiary, that the company’s Board of Directors resolved to change the date for 2021 annual shareholders’ meeting
1.Date of the board of directors’ resolution: September 9,2021 2.Shareholders meeting date: October 27,2021 3.Shareholders meeting location:5th Floor, No.19, Shengyi 5th Rd., Zhubei City, Hsinchu County 4.Cause for convening the …
Supplementary announcement of electronic voting shareholders’ complimentary gift for 2021 annual shareholders’ meeting
1.Date of occurrence of the event: September 7, 2021 2.Company name: OBI Pharma Inc. 3.Relationship to the Company (please enter “head office” or “subsidiaries”): Head office 4.Reciprocal shareholding ratios: Not …
The Company’s Board of Directors resolved to issue employee stock options and the subscription rules
1. Date of the Board of Directors resolution: 2021/08/06 2. Issue period: Pursuant to the “Regulations Governing the Offering and Issuance of Securities by Securities Issuers,” issued within one year …
New appointment of Audit Committee member
1. Date of occurrence of the change: August 6, 2021 2. Name of the functional committees: Audit Committee 3. Name and resume of the previous position holder: None 4. Name …
Announcement of the Consolidated Financial Statements for the second quarter of 2021 were authorized for issuance by the Board of Directors
1. Date of the financial reports submitted to the board of directors or approved by the board of directors: August 6, 2021 2. Date of the financial reports approved by …
Patent of OBI-858 “Clostridium Botulinum toxin Type A composition, formulation and use thereof” was granted by the Taiwan Intellectual Property Office
1. Date of occurrence of the event: July 27, 2021 2. Company name: OBI Pharma Inc. 3. Relationship to the Company (please enter “head office” or “subsidiaries”): Head office 4. …
Announcement to approve the lifting of non-competition restrictions for directors at the 2021 Annual General Meeting
1. Date of the shareholders’ meeting resolution: July 16, 2021 2. Name and title of the managerial officer with permission to engage in competitive conduct: Independent Director: Howard Lee Director: …